Innealta Capital, LLC Spring Works Therapeutics, Inc. Transaction History

Innealta Capital, LLC

  • $201 Million
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024
BUY
$36.06 - $47.62 $1,153 - $1,523
32 New
32 $1,000

About SpringWorks Therapeutics, Inc.

SWTX Quotes by TradingView
  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $1.87B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Innealta Capital, LLC Portfolio

Follow Innealta Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Innealta Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Innealta Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email